Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Macromolecular Bioscience

• Publication date

  2014-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/mabi.201300333PMID 24106137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo

  2012cited by this paper
• Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis.

  2012cited by this paper
• Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

  2012cited by this paper
• Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition.

  2012cited by this paper
• Temperature induced micellization and aggregation of biocompatible poly (oligo(ethylene glycol)methyl ether methacrylate) block copolymer analogs in aqueous solutions

  2012cited by this paper
• Polymer nanoparticles: Preparation techniques and size-control parameters

  2011cited by this paper
• Cationic Nanogels Based On Diethylaminoethyl Methacrylate.

  2010cited by this paper
• Emerging applications of stimuli-responsive polymer materials.

  2010cited by this paper
• Synthesis and characterization of thermoresponsive poly(ethylene glycol)‐based hydrogels and their magnetic nanocomposites

  2010cited by this paper
• Self‐Assembling Peptide as a Potential Carrier for Hydrophobic Anticancer Drug Ellipticine: Complexation, Release and In Vitro Delivery

  2009cited by this paper
• Sequence Effect of Self-Assembling Peptides on the Complexation and In Vitro Delivery of the Hydrophobic Anticancer Drug Ellipticine

  2008cited by this paper
• Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles.

  2007cited by this paper
• Point by point comparison of two thermosensitive polymers exhibiting a similar LCST: is the age of poly(NIPAM) over?

  2006cited by this paper
• Solvent effect on the photophysical properties of the anticancer agent ellipticine.

  2006cited by this paper
• Poly(DEAEMa-co-PEGMa): a new pH-responsive comb copolymer stabilizer for emulsions and dispersions.

  2006cited by this paper
• Synthesis and characterization of novel pH-responsive polyampholyte microgels

  2006cited by this paper
• Preparation of Ideal PEG Analogues with a Tunable Thermosensitivity by Controlled Radical Copolymerization of 2-(2-Methoxyethoxy)ethyl Methacrylate and Oligo(ethylene glycol) Methacrylate

  2006cited by this paper
• Topoisomerase Inhibitors of Marine Origin and Their Potential Use as Anticancer Agents

  2005cited by this paper
• Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent.

  2005cited by this paper
• Plant-based anticancer molecules: a chemical and biological profile of some important leads.

  2005cited by this paper
• Reversible inside-out micellization of pH-responsive and water-soluble vesicles based on polypeptide diblock copolymers.

  2005cited by this paper
• pH‐Triggered Thermally Responsive Polymer Core–Shell Nanoparticles for Drug Delivery

  2005cited by this paper
• Extending nature's leads: the anticancer agent ellipticine.

  2004cited by this paper
• Cellular localisation of chromogranins and processed products in the diffuse neuroendocrine system and related tumours

  2004cited by this paper
• Controlled polymerizations of 2-(dialkylamino)ethyl methacrylates and their block copolymers in protic solvents at ambient temperature via ATRP

  2004cited by this paper
• Synthesis of polystyrene/poly[2-(dimethylamino)ethyl methacrylate-stat-ethylene glycol dimethacrylate] core-shell latex particles by seeded emulsion polymerization and their application as stimulus-responsive particulate emulsifiers for oil-in-water emulsions.

  2004cited by this paper
• Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine.

  2004cited by this paper
• Novel pH Responsive Amphiphilic Diblock Copolymers with Reversible Micellization Properties

  2003cited by this paper
• N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.

  2001cited by this paper
• The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.

  2001cited by this paper
• The endocytic pathway: a mosaic of domains

  2001cited by this paper
• Effect of cross-link density on the internal structure of poly(N-isopropylacrylamide) microgels

  2001cited by this paper
• Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug.

  1998cited by this paper
• Controlled/"Living" Radical Polymerization of 2-(Dimethylamino)ethyl Methacrylate.

  1998cited by this paper
• Synthesis and aqueous solution properties of novelhydrophilic–hydrophilic block copolymers based on tertiary aminemethacrylates

  1997cited by this paper
• Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA.

  1995cited by this paper
• DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.

  1992cited by this paper
• Kinetic and thermodynamic studies on drug-DNA interactions in the ellipticine series.

  1990cited by this paper
• Synthetic polyampholytes. 5. Influence of nearest-neighbor interactions on potentiometric curves

  1987cited by this paper
• Phase II study of 9-hydroxy-2N-methylellipticinium acetate.

  1984cited by this paper
• Static and dynamic light scattering from branched polymers and biopolymers

  1983cited by this paper
• Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule.

  1982cited by this paper
• Determination of ellipticine in biological samples by high-performance liquid chromatography.

  1982cited by this paper
• Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma.

  1981cited by this paper
• Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

  1980cited by this paper
• A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

  1974cited by this paper
• Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazoles

  1967cited by this paper

• Core–Shell Particles: From Fabrication Methods to Diverse Manipulation Techniques

  2023cites this paper
• Ellipticine, its Derivatives: Re-Evaluation of Clinical Suitability with the Aid of Drug Delivery Systems.

  2019cites this paper
• Direct site-specific treatment of skin cancer using doxorubicin-loaded nanofibrous membranes.

  2017cites this paper
• Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH.

  2016cites this paper
• Formation of DNA Adducts by Ellipticine and Its Micellar Form in Rats — A Comparative Study

  2014cites this paper
• Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles

  2014cites this paper